CoChat

Effect of Bifidobacterium bifidum on Clinical Characteristics and Gut Microbiota in Attention-Deficit/Hyperactivity Disorder

Open access

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

This study aimed to examine whether probiotics supplements using Bifidobacterium bifidum (Bf-688) can improve clinical characteristics and gut microbiomes among patients with attention-deficit/hyperactivity disorder (ADHD). This open-label, single-arm trial consisted of 30 children aged 4–16 years who met the criteria for ADHD diagnosis. Each subject took Bf-688, with one sachet in the morning and one in the evening (daily bacteria count 5 × 109 CFUs), for 8 weeks. Patients’ clinical symptoms were assessed using the Swanson, Nolan, and Pelham Rating Scale (SNAP-IV). We collected stool samples at the baseline, the 8th week, and the 12th week for gut microbiota examination. During the 8-week Bf-688 supplement period, patients’ inattention symptoms and hyperactivity/impulsive symptoms improved, and their weights and BMIs increased. For gut microbiota, the Firmicutes to Bacteroidetes ratio (F/B ratio) decreased significantly. LEfSe analysis revealed that Firmicutes significantly decreased while Proteobacteria significantly increased during the 8-week treatment period. After Bf-688 was discontinued for 4 weeks (12 weeks from baseline), Bacteroidota significantly decreased and Shigella significantly increased. The probiotic Bf-688 supplement was associated with an improvement of clinical symptoms and with weight gain among ADHD children. Furthermore, gut microbiota composition was significantly altered by the Bf-688 supplement. A future randomized control trial is warranted to verify these findings.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jpm12020227

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 ADHD inattention symptoms (A), hyperactivity/impulsive symptoms (B), patients’ body weight (C) and BMI (D) during the eight-week period of ADHD patients receiving oral probiotic supplements (Bifidobacterium bifidum, Bf-688). * p < 0.05, ** p < 0.01.
Figure 1 ADHD inattention symptoms (A), hyperactivity/impulsive symptoms (B), patients’ body weight (C) and BMI (D) during the eight-week period of ADHD patients receiving oral probiotic supplements (Bifidobacterium bifidum, Bf-688). * p < 0.05, ** p < 0.01.CC BY · PubMed Central
Figure 2 Abundance of the most prevalent bacteria at the phylum level in the fecal samples of ADHD patients at baseline, week 8, and week 12.
Figure 2 Abundance of the most prevalent bacteria at the phylum level in the fecal samples of ADHD patients at baseline, week 8, and week 12.CC BY · PubMed Central
Figure 3 The Firmicutes to Bacteroidetes ratio (F/B ratio) at baseline, week 8, and week 12. Statistical analyses used analysis of variance (ANOVA) (A) and the Kruskal–Wallis test (B). * p < 0.05, ** p < 0.01.
Figure 3 The Firmicutes to Bacteroidetes ratio (F/B ratio) at baseline, week 8, and week 12. Statistical analyses used analysis of variance (ANOVA) (A) and the Kruskal–Wallis test (B). * p < 0.05, ** p < 0.01.CC BY · PubMed Central
Figure 4 Bacterial taxonomic distributions of phylum levels in ADHD patients at baseline, week 8, and week 12.
Figure 4 Bacterial taxonomic distributions of phylum levels in ADHD patients at baseline, week 8, and week 12.CC BY · PubMed Central
Figure 5 The Simpson index (A) and Shannon index (B) among ADHD patients at baseline, week 8, and week 12.
Figure 5 The Simpson index (A) and Shannon index (B) among ADHD patients at baseline, week 8, and week 12.CC BY · PubMed Central
Figure 6 Flora with significant differences between baseline and the 8th week (A) and between baseline and the 12th week (B). The orange bars represent flora with higher abundances after taking probiotics (week 8). The blue bars show flora with higher expressions at the baseline.
Figure 6 Flora with significant differences between baseline and the 8th week (A) and between baseline and the 12th week (B). The orange bars represent flora with higher abundances after taking probiotics (week 8). The blue bars show flora with higher expressions at the baseline.CC BY · PubMed Central
Figure 7 The dominant species and species abundances of each sample shown with those having abundances greater than 1% of the species (ASVs) appearing in at least one sample. The p-values between the two-group statistics (Wilcoxon rank-sum test) or the multi-group statistics (Kruskal–Wallis test). The values are sorted from small to large, and the top 30 dominant species with differences between groups are selected for the circle chart. A solid circle indicates the statistical threshold reached (p < 0.05), and a hollow circle represents a species under the statistical threshold.
Figure 7 The dominant species and species abundances of each sample shown with those having abundances greater than 1% of the species (ASVs) appearing in at least one sample. The p-values between the two-group statistics (Wilcoxon rank-sum test) or the multi-group statistics (Kruskal–Wallis test). The values are sorted from small to large, and the top 30 dominant species with differences between groups are selected for the circle chart. A solid circle indicates the statistical threshold reached (p < 0.05), and a hollow circle represents a species under the statistical threshold.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Cited by

See all 58

Metadata

Authors
Wang, L.-J., Yang, C.-Y., Kuo, H.-C., Chou, W.-J., Tsai, C.-S., & Lee, S.-Y.
Affiliations
  • Chang Gung University (TW)
  • Kaohsiung Medical University (TW)
Corresponding author
Wang, Liang-Jen
Venue
Journal of Personalized Medicine
Publisher
MDPI AG
Published
2022-02-07
Volume
12
Issue
2
Pages
227
ISSN
2075-4426 (ISSN-L)
OpenAlex
W4210938627
Cited by
58
References
53
Citations by year
2026: 10 · 2025: 20 · 2024: 16 · 2023: 8 · 2022: 4
FWCI
6.38
Type
journal article
Language
en
Open access
Locations
  • Journal of Personalized Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Kaohsiung Chang Gung Memorial Hospital (CMRPG8K0761 & CMRPG8M0031)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
Keywords
Bifidobacterium bifidum, probiotics, attention deficit hyperactivity disorder, gut microbiota, children, inattention, hyperactivity/impulsivity, Firmicutes/Bacteroidetes ratio, weight gain, body mass index, Shigella, Proteobacteria

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Bifidobacterium bifidum on Clinical Characteristics and Gut Microbiota in Attention-Deficit/Hyperactivity Disorder. https://app.cochat.ai/papers/10.3390/jpm12020227
The paper
Wang, L.-J., Yang, C.-Y., Kuo, H.-C., Chou, W.-J., Tsai, C.-S., & Lee, S.-Y. (2022). Effect of Bifidobacterium bifidum on Clinical Characteristics and Gut Microbiota in Attention-Deficit/Hyperactivity Disorder. Journal of Personalized Medicine. https://doi.org/10.3390/jpm12020227

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.